BRIEF-UK's CMA Says Aramark / Entier Merger Will Move To In-Depth Phase 2 Investigation-February 2024-www.financetom.com

BRIEF-UK's CMA Says Aramark / Entier Merger Will Move To In-Depth Phase 2 Investigation

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-UK's CMA Says Aramark / Entier Merger Will Move To In-Depth Phase 2 Investigation

Aug 5, 2025 6:15 AM

Aug 5 (Reuters) -

UK's CMA:

* UK'S CMA: ARAMARK'S ( ARMK ) COMPLETED PURCHASE OF ENTIER WILL MOVE

TO AN

IN-DEPTH PHASE 2 INVESTIGATION

* UK'S CMA: CONCERNED DEAL MAY LEAD TO HIGHER PRICES AND/OR

LACK

OF CHOICE FOR COS THAT PROVIDE ON-SITE CATERING TO STAFF BASED

AT SEA

Source text:

Further company coverage:

Previous page： Microsoft to Launch Autonomous AI Agent Creation Function Via Copilot Studio Next page： Regeneron Says Eylea HD Sustains Vision Gains in Diabetic Macular Edema in Extension Study

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Microsoft to Launch Autonomous AI Agent Creation Function Via Copilot Studio

Oct 21, 2024

08:10 AM EDT, 10/21/2024 (MT Newswires) -- Microsoft ( MSFT ) said in a blog post Monday it will start allowing customers to create autonomous artificial intelligence agents using the Copilot Studio application from next month. The AI agents will work on behalf of an individual, team or function to execute and orchestrate businesses process, Microsoft ( MSFT ) said...

Regeneron Says Eylea HD Sustains Vision Gains in Diabetic Macular Edema in Extension Study

Oct 21, 2024

08:04 AM EDT, 10/21/2024 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said late Friday that its eye disease drug Eylea HD showed continued durable vision gains and anatomic improvements in most of the patients with diabetic macular edema in a phase 3 extension study. The company said slower fluid reaccumulation was noted in patients who switched to Eylea HD...

Newport Exploration Noted Beach Energy's Q1 Activities Report

Oct 21, 2024

08:07 AM EDT, 10/21/2024 (MT Newswires) -- Newport Exploration ( NWXPF ) over the weekend provided an update for licences in the Cooper basin, Australia, over which the company has a 2.5% gross overriding royalty. It noted the information was reported by Beach Energy Ltd in its FY25 First Quarter Activities Report dated October 18, 2024. ...

Nigeria fails to approve Shell asset sale to Renaissance

Oct 21, 2024

ABUJA (Reuters) - Nigeria has failed to approve the sale of Shell's entire onshore and shallow-water oil and gas in the Niger Delta region to Renaissance, the country's upstream regulator said on Monday. A presentation by Nigerian Upstream Petroleum Regulatory Commission (NUPRC) CEO Gbenga Komolafe at an event in the capital Abuja showed consent declined, referring to the Shell-Renaissance deal....